Juniper Pharmaceuticals Inc (NASDAQ:JNP)

8.55
Delayed Data
As of 12:34pm ET
 -0.10 / -1.16%
Today’s Change
3.90
Today|||52-Week Range
13.25
+76.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$100.8M

Company Description

Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a pharmaceutical company that engages in the development of therapeutics that addresses unmet medical needs in women's health. Its pipeline development is funded by cash flows from its CRINONE franchise and services business. It is currently developing COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecological procedures. The company was founded in December 1986 and is headquartered in Boston, MA.

Contact Information

Juniper Pharmaceuticals, Inc.
31st Floor
Boston Massachusetts 02110
P:(617) 639-1500
Investor Relations:

Employees

Shareholders

Individual stakeholders7.87%
Other institutional27.63%
Mutual fund holders14.16%

Top Executives

Alicia SecorPresident, Chief Executive Officer & Director
Nikin PatelChief Operating Officer & Director
Jeffrey E. YoungChief Financial Officer, Secretary & Treasurer
Shen LukChief Scientific Officer